Q. Tang, Z. Q. Li, W. Li, et al.: The 5-HT2 antagonist ketanserin is an open channel blocker of human cardiac ether-à-go-go-related gene (hERG) potassium channels. In: Br J Pharmacol. Band155, Nr.3, Oktober 2008, S.365–373, doi:10.1038/bjp.2008.261, PMID 18574455, PMC 2567890 (freier Volltext).
Franz X. Vollenweider, Erich Seifritz, Jan Flemming, Thomas Pokorny, Leonhard Schilbach: Role of the 5-HT2A Receptor in Self- and Other-Initiated Social Interaction in Lysergic Acid Diethylamide-Induced States: A Pharmacological fMRI Study. In: Journal of Neuroscience. Band38, Nr.14, 4. April 2018, S.3603–3611, doi:10.1523/JNEUROSCI.1939-17.2018, PMID 29555857 (jneurosci.org [abgerufen am 11. Februar 2019]).
Patent EP0098499: Process of preparing ketanserine. Angemeldet am 27. Juni 1983, veröffentlicht am 18. Januar 1987, Anmelder: Ravizza S.p.A., Erfinder: Roberto Signorini, Alberto Verga.
Franz X. Vollenweider, Erich Seifritz, Jan Flemming, Thomas Pokorny, Leonhard Schilbach: Role of the 5-HT2A Receptor in Self- and Other-Initiated Social Interaction in Lysergic Acid Diethylamide-Induced States: A Pharmacological fMRI Study. In: Journal of Neuroscience. Band38, Nr.14, 4. April 2018, S.3603–3611, doi:10.1523/JNEUROSCI.1939-17.2018, PMID 29555857 (jneurosci.org [abgerufen am 11. Februar 2019]).
P. A. van Zwieten, G. J. Blauw, P. van Brummelen: Pharmacological profile of antihypertensive drugs with serotonin receptor and alpha-adrenoceptor activity. In: Drugs. Band40, Suppl 4, 1990, S.1–8; discussion 28–30, PMID 1982649.
J. Marin, J. Reviriego, M. S. Fernandez-Alfonso: Ability of ketanserin to block different receptors in human placental vessels. In: J. Pharm. Pharmacol. Band42, Nr.3, März 1990, S.217–220, PMID 1974625.
Q. Tang, Z. Q. Li, W. Li, et al.: The 5-HT2 antagonist ketanserin is an open channel blocker of human cardiac ether-à-go-go-related gene (hERG) potassium channels. In: Br J Pharmacol. Band155, Nr.3, Oktober 2008, S.365–373, doi:10.1038/bjp.2008.261, PMID 18574455, PMC 2567890 (freier Volltext).
P. Vanhoutte, A. Amery, W. Birkenhäger, et al.: Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin. In: Hypertension. Band11, Nr.2, Februar 1988, S.111–133, PMID 3277910.
D. W. Steyn, H. J. Odendaal: Serotonin antagonism and serotonin antagonists in pregnancy: role of ketanserin. In: Obstet Gynecol Surv. Band55, Nr.9, September 2000, S.582–9, PMID 10975485.
Franz X. Vollenweider, Erich Seifritz, Jan Flemming, Thomas Pokorny, Leonhard Schilbach: Role of the 5-HT2A Receptor in Self- and Other-Initiated Social Interaction in Lysergic Acid Diethylamide-Induced States: A Pharmacological fMRI Study. In: Journal of Neuroscience. Band38, Nr.14, 4. April 2018, S.3603–3611, doi:10.1523/JNEUROSCI.1939-17.2018, PMID 29555857 (jneurosci.org [abgerufen am 11. Februar 2019]).